Skip to main content

Table 3 Comparison of blood indexes in PD patients with different disease durations

From: Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson’s disease

  < 6 years 6 ~ 10 years > 10 years χ2/F P
N (%) 55 (56.1) 29 (29.6) 14 (14.3) / /
WBCs (×109/L) 5.76 (5.08 ~ 6.61)b 5.53 (4.77 ~ 6.31)c 4.55 (4.09 ~ 5.6) 11.237 0.004
Neutrophils (× 109/L) 3.61 (3.1 ~ 4.51)b 3.52 (2.92 ~ 4.45) 2.79 (2.61 ~ 3.42) 7.963 0.019
Lymphocytes (×109/L) 1.54 ± 0.47 1.51 ± 0.62 1.24 ± 0.27 2.129 0.125
Monocytes (×109/L) 0.38 ± 0.1a 0.44 ± 0.13c 0.35 ± 0.07 4.072 0.02
Hb (×109/L) 159 (150 ~ 166) 160 (154.5 ~ 165) 150.5 (141.5 ~ 165) 4.503 0.105
UA (μmol/L) 303 (224 ~ 359) 294 (266 ~ 334) 289 (268 ~ 349.5) 0.034 0.983
TC (mmol/L) 4.42 ± 0.8 3.96 ± 0.89 4.25 ± 0.72 3.041 0.052
TG (mmol/L) 1.25 (0.94 ~ 1.83) 1.02 (0.8 ~ 1.61) 1.03 (0.53 ~ 1.18) 5.557 0.062
HDL-C (mmol/L) 1.17 ± 0.29 1.13 ± 0.28 1.3 ± 0.3 1.699 0.188
LDL-C (mmol/L) 2.53 ± 0.73 2.31 ± 0.68 2.43 ± 0.5 0.99 0.375
MHR (×109/mmol) 0.33 (0.25 ~ 0.41) 0.41 (0.26 ~ 0.51)c 0.27 (0.25 ~ 0.32) 7.477 0.024
NHR (×109/mmol) 3.3 (2.45 ~ 4.14)b 3.26 (2.41 ~ 4.61)c 2.07 (1.96 ~ 2.96) 9.975 0.007
NLR (×109/mmol) 2.56 (2.01 ~ 3.41) 2.58 (1.97 ~ 3.39) 2.69 (2.11 ~ 2.87) 0.085 0.958
  1. a< 6 years vs. 6 ~ 10 years, P < 0.05; b: < 6 years vs. > 10 years, P < 0.05; c: 6 ~ 10 years vs. > 10 years, P < 0.05